Researchers from University of Utah Report Findings in Managed Care and Specialty Pharmacy (Optimization of Oncology Biomarker Testing In Managed Care: Best Practices and Consensus Recommendations From an Amcp Market Insights Program): Drugs and Therapies – Managed Care and Specialty Pharmacy

2025 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Researchers detail new data in Drugs and Therapies - Managed Care and Specialty Pharmacy. According to news reporting originating from Salt Lake City, Utah, by NewsRx correspondents, research stated, “Precision medicine in oncology using actionable molecular biomarkers to guide treatment selection has been associated with favorable outcomes; however, many potentially eligible patients do not receive it. This Academy of Managed Care Pharmacy Market Insights program sought to characterize unmet needs in biomarker testing among managed care stakeholders, to develop best practice and consensus recommendations to support addressing these needs, and to gain insights on potential quality measures related to biomarker testing.”

Our news editors obtained a quote from the research from the University of Utah, “The program used a modified Delphi process and included in-depth interviews with expert panelists, a national survey of managed care professionals, and a consensus survey of experts. Areas of unmet need in biomarker testing identified were education, guidelines and protocols, timeliness, process, and equity. Twenty-two best practices were suggested by managed care experts and other stakeholders; 9 of these best practices achieved consensus. These consensus recommendations addressed biomarker test ordering and test performance, treatment decisions based on biomarker testing, cost-effectiveness of biomarker testing, and health disparities in access to biomarker testing. Opportunities for education and improvements in infrastructure to implement these recommendations were identified.”

According to the news editors, the research concluded: “Further investigation is needed to develop quality measures; although, valuable insights were gained.”

This research has been peer-reviewed.

For more information on this research see: Optimization of Oncology Biomarker Testing In Managed Care: Best Practices and Consensus Recommendations From an Amcp Market Insights Program. Journal of Managed Care & Specialty Pharmacy, 2025;31(6). Journal of Managed Care & Specialty Pharmacy can be contacted at: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

The news editors report that additional information may be obtained by contacting Diana Brixner, University of Utah, Dept. of Pharmacotherapy, Salt Lake City, UT 84112, United States. Additional authors for this research include Catherine M. Lockhart, Scott Ramsey, John Fox, Daryl Pritchard, Howard Mcleod, Laura Bobolts, Brian Bourbeau and Erin Crum.

(Our reports deliver fact-based news of research and discoveries from around the world.)